AMPH FY 2021 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$894M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$438M+25.1% YoY

Gross Profit

$200M45.6% margin

Operating Income

$70M16.0% margin

Net Income

$62M14.2% margin

EPS (Diluted)

$1.25

Cash Flow

Operating Cash Flow

$98M

Free Cash Flow

$71M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$672M

Total Liabilities

$226M

Stockholders' Equity

$446M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$438M	$350M	+25.1%
Gross Profit	$200M	$143M	+39.3%
Operating Income	$70M	$11M	+538.0%
Net Income	$62M	$1M	+4327.4%